Drug recall
Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC…
FDA recall event 67606 · Class III · Viiv Healthcare Company
Key facts
| Event ID | 67606 |
|---|---|
| Recall numbers | D-1185-2014 |
| Recalling firm | Viiv Healthcare Company |
| Product type | Drugs |
| Products | Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, Research Triangle Park, NC 27709. Made in Japan. NDC 49702-228-13 |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Cross Contamination with Other Products: Product contains Promacta (eltrombopag). |
| Initiation date | Feb 11, 2014 |
| Report date | Apr 9, 2014 |
| Termination date | Aug 21, 2014 |
| City | Durham |
| State | NC |
| Country | United States |
| FEI number | 3008108109 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: